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In developing countries, Salmonella enterica serovar 
Enteritidis causes substantial illness and death, and drug 
resistance is increasing. Isolates from the United Kingdom 
containing virulence-resistance plasmids were character-
ized. They mainly caused invasive infections in adults linked 
to Africa. The common features in isolates from these conti-
nents indicate the role of human travel in their spread.
W
orldwide, nontyphoidal Salmonella enterica is a 
major cause of foodborne illness, and Enteritidis 
is one of the most commonly reported serovars (www.
who.int/salmsurv/links/GSSProgressReport2005.pdf). In 
industrialized countries, S.  enterica serovar Enteritidis 
commonly causes self-limiting gastroenteritis, for which 
treatment with antimicrobial drugs is usually not needed. 
However, in developing countries, this serovar, together 
with serovar Typhimurium, frequently causes invasive 
infections and substantial illness and death among young 
children with underlying diseases and among adults with 
HIV infection (1). Although antimicrobial drug resistance 
is not as high in S. enterica serovar Enteritidis as in other 
zoonotic disease serovars, multidrug-resistance (resistance 
to >4 antimicrobial drugs) has been increasingly reported 
(2), threatening treatment success for patients with severe 
infections. In recent years, in association with multidrug 
resistance, another trend has arisen: the emergence of 
virulence-resistance (VR) plasmids; these are hybrid 
plasmids that harbor resistance (R) and virulence (V) 
determinants. The appearance of these plasmids is of 
concern because they could lead to the co-selection of 
virulence (in addition to resistance) through the use 
of antimicrobial drugs (3,4). One such plasmid, pUO-
SeVR1, has been recently reported in a multidrug-resistant 
(MDR) clinical isolate of S. enterica serovar Enteritidis 
(CNM4839/03) from Spain (5). This mobilizable plasmid of 
≈100 kb derives from pSEV, the serovar-speciﬁ  c V plasmid 
of S. enterica serovar Enteritidis, and carries most of its V 
determinants, including the spvRABCD locus (Salmonella 
plasmid virulence). This plasmid greatly increases the 
ability of salmonellae to proliferate intracellularly and 
has been associated with severe infections in humans 
(6). The plasmid also harbors several R genes—blaTEM-1, 
catA2, strA-strB, sul1, sul2, tet(A)—and a class-1 integron 
with the 700-bp/dfrA7 variable region, which confer 
resistance to ampicillin, chloramphenicol, streptomycin, 
sulfonamides, tetracycline, and trimethoprim (R-type 
ACSSuTTm). To investigate their international spread, 
we studied the presence of S. enterica serovar Enteritidis 
isolates carrying pUO-SeVR1–like plasmids in the United 
Kingdom.
The Study
We screened 31,615 S. enterica serovar Enteritidis 
isolates that had been collected from clinical specimens 
during 2005–2010 and deposited in the culture collection of 
the Health Protection Agency Salmonella Reference Unit.   
We screened the isolates for R-type ACSSuTTm. A total 
of 14 serovar Enteritidis isolates showing this resistance 
phenotype were detected and subsequently examined for 
the presence of integron-located dfrA7. Of the 14 isolates, 
11 were positive and their plasmid content was analyzed 
by S1 pulsed-ﬁ  eld gel electrophoresis (PFGE) (2) and by 
the Kado and Liu methods (7); we used serovar Enteritidis 
strains NRL-Salm-PT4 and CNM4839/03 as controls for 
pSEV– and pUO-SeVR1–carrying isolates, respectively. 
The 11 isolates harbored 1 plasmid of variable size (60–95 
kb); among these, 9 isolates hybridized with dfrA7-speciﬁ  c 
and  spvC-speciﬁ   c probes (with plasmids of 85–95 kb) 
(Figure). These 9 isolates contained a VR-hybrid plasmid 
similar to pUO-SeVR1 and were selected for further 
analyses (Tables 1, 2). The remaining 2 isolates carried the 
normal pSEV plasmid (60 kb), in which spvC hybridized; 
dfrA7 was chromosomally located.
In the 9 isolates carrying VR-hybrid plasmids, the 
R-type ACSSuTTm was encoded by the R-genes blaTEM-1, 
catA2, strA-strB, sul1, sul2, tet(A), and dfrA7, which were 
located on the pUO-SeVR1–like plasmids as determined 
by Southern blot hybridization. By PCR ampliﬁ  cation, 
using previously described primers and conditions (5,8) 
(Table 2), and by Southern blot hybridization (5), we tested 
for the presence of IncFII and IncFIB replicons, parAB 
(partition),  spvRABCD,  rck (resistance to complement 
killing),  mig-5 (macrophage-induced gene), pefABCDI 
(Pef ﬁ  mbriae operon), and srgA (SdiA-regulated gene; next 
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for the 2 replicons and for all genes screened except pefC 
and pefD (absent in H070360201 and H070420137), pefI-
orf7 (absent in all), and srgA (either absent [H051860415, 
H073180204, and H091800482] or truncated [in the 
remaining isolates]) (Table 2).
Isolate subtyping was conducted by phage typing, 
multilocus variable number tandem repeat analysis 
(MLVA), multilocus sequence typing (MLST), and XbaI-
PFGE (9,10) (http://mlst.ucc.ie/mlst/dbs/Senterica; www.
pulsenetinternational.org). The 9 S. enterica serovar 
Enteritidis isolates belong to phage type (PT) 42, in 
contrast with CNM4839/03, which belongs to PT14b 
(Table 2). We identiﬁ  ed 4 MLVA proﬁ  les, which were all 
single-locus variants of the highly variable locus SENTR5, 
indicating that the isolates are closely related (Table 2). The 
isolate from Spain and 3 of the 9 isolates from the United 
Kingdom, selected as representative of each MLVA proﬁ  le, 
were also analyzed by MLST (Table 2). CNM4839/03 and 
H091340084 were assigned to sequence type (ST) 11, the 
most commonly found ST in serovar Enteritidis (http://mlst.
ucc.ie/mlst/). The remaining 2 isolates could be ascribed to 
ST1479, the ﬁ  rst examples of this single-locus variant of 
ST11 in the MLST database (Table 2). According to XbaI-
PFGE, the control strain NRL-Salm-PT4 showed a clearly 
distinct proﬁ  le in comparison with CNM4839/03 and the 
9 isolates containing pUO-SeVR1–like plasmids, which 
generated 6 closely related patterns (Figure). Most isolates 
differed by 1 band of variable size (85–95 kb), which 
corresponded to the XbaI-linearized VR-hybrid plasmids. 
As an exception, isolate H070420137 showed additional 
differences in chromosomal bands of ≈150 and ≈300 kb. 
Because isolates H070420137 and H070360201 came 
from the same patient (Table 1) and shared the same V 
and R genotypes and other typing markers, 1 isolate could 
have evolved from the other; however, co-infection of the 
patient with 2 closely related strains cannot be ruled out. 
In addition, considering the typing results of H095100307, 
H100240198, and H101700366, the identical size of their 
plasmids, and the fact that they were isolated from the same 
patient (Table 1), these 3 isolates can be considered the 
same strain.
All except 2 of the UK isolates carrying pUO-SeVR1–
like plasmids were recovered from the blood of patients who 
had recently returned from an African country or who had 
an African name (Table 1). Supporting the possible African 
origin, similar XbaI-PFGE proﬁ  les and MDR phenotypes 
(ampicillin, trimethoprim, sulfonamides, and tetracycline) 
have been identiﬁ   ed in clinical S. enterica serovar 
Enteritidis isolates involved in outbreaks and community 
infections in different African countries. These isolates 
caused bacteremia, meningitis, diarrhea (11–13), and high 
case-fatality rates; they affected mainly children, whereas 
most clinical isolates analyzed in our study were obtained 
from adults with bacteremia (Table 1). The detection of 
the 700-bp/dfrA7 integron in S. enterica serovar Enteritidis 
isolates from Africa (14) also supports an African origin 
of the MDR serovar Enteritidis isolates harboring pUO-
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Figure. Genomic macrorestriction of Salmonella enterica serovar 
Enteritidis isolates: pulsed-ﬁ  eld gel electrophoresis proﬁ  les for XbaI 
(left panel) and S1 (right panel). Lane M, XbaI-digested DNA of S. 
enterica serovar Braenderup H9812, used as size standard; lane 
1, NRL-Salm-PT4; lane 2, CNM4839/03; lane 3, H051860415; lane 
4, H070360201; lane 5, H070420137; lane 6, H073180204; lane 
7, H091340084; lane 8, H091800482; lane 9, H095100307; lane 
10, H100240198; lane 11, H101700366. The strain NRL-Salm-PT4 
was used as control for the most commonly found XbaI-proﬁ  le in S. 
enterica serovar Enteritidis.
Table 1. Epidemiologic information for multidrug-resistant Salmonella enterica serovar Enteritidis isolates, 2005–2010, UK* 
Isolate no. Date of isolation Source Recent travel history African patient name  Patient age, y
CNM4839/03† 2003 Feces Unknown No 3
H051860415 2005 Apr 19 Blood Nigeria No 38
H070360201‡ 2007 Jan 14 Blood Unknown Yes  35
H070420137‡ 2007 Jan 15 Feces Unknown Yes  35
H073180204 2007 Jul 31 Blood Unknown Yes  34
H091340084 2009 Mar 15 Feces Uganda No 59
H091800482 2009 Apr 17 Blood Unknown Yes  30
H095100307§ 2009 Dec 7 Blood Unknown Yes  68
H100240198§ 2010 Jan 9 Blood Unknown Yes  68
H101700366§ 2010 Apr 22 Blood Unknown Yes  68
*All isolates contained a virulence-resistance hybrid plasmid similar to pUO-SeVR1. 
†Control isolate from Spain. 
‡Recovered from the same patient. 
§Recovered from the same patient. Invasive S. enterica serovar Enteritidis
SeVR1–like plasmids. Of note, resistance derivatives of 
pSLT, the V-plasmid speciﬁ  c to S. Typhimurium, have 
been found in the epidemic ST313 clone of this serovar, 
which has been considered a major cause of invasive 
disease in sub-Saharan Africa (15).
Conclusions
Closely related MDR S. enterica serovar Enteritidis 
isolates carrying pUO-SeVR1–like plasmids were 
recovered in the United Kingdom. Most were isolated from 
the blood of patients linked to Africa, and they showed 
common features with serovar Enteritidis isolates involved 
in outbreaks on that continent. The possibility that this 
potentially invasive clone of S. enterica serovar Enteritidis 
can be spread through human travel, together with the 
detection of VR-plasmids in the serovar most frequently 
associated with human infections, is of public health 
concern and requires surveillance.
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Table 2. Characteristics of Salmonella enterica serovar Enteritidis isolates harboring pUO-SeVR1-like plasmids, 2005–2010, UK* 
Isolate no.
Phage
type
Resistance phenotype/ 
genotype
Class 1 
integron† pSEV genes‡ MLVA MLST
VR
plasmid, kb
CNM4839/03 PT 14b AMP, CHL, STR, SUL, 
TET, TMP/blaTEM-1,
catA2, strA-strB, sul1, 
sul2, tet(A), dfrA7
700 bp/dfrA7 spvA, spvB, spvC, 
spvR, rsk, rck, mig-5,
srgB, srgC, pefA, 
pefB, pefC, pefD
2-12-9-4-4-3-NA-8-8 ST11 100
H051860415 PT 42 AMP, CHL, STR, SUL, 
TET, TMP/blaTEM-1,
catA2, strA-strB, sul1, 
sul2, tet(A), dfrA7
700 bp/dfrA7 spvA, spvB, spvC, 
spvR, rsk, rck, mig-5, 
srgB, srgC, pefA, 
pefB, pefC, pefD
2-13-9-4-4-3-NA-8-8 ST1479 95
H070360201 PT 42 AMP, CHL, STR, SUL, 
TET, TMP/blaTEM-1,
catA2, strA-strB, sul1, 
sul2, tet(A), dfrA7
700 bp/dfrA7 spvA, spvB, spvC, 
spvR, rsk, rck, mig-5, 
ǻsrgA, srgB, srgC, 
pefA, pefB
2-15-9-4-4-3-NA-8-8 ST1479 88
H070420137 PT 42 AMP, CHL, STR, SUL, 
TET, TMP/blaTEM-1,
catA2, strA-strB, sul1, 
sul2, tet(A), dfrA7
700 bp/dfrA7 spvA, spvB, spvC, 
spvR, rsk, rck, mig-5, 
ǻsrgA, srgB, srgC, 
pefA, pefB
2-15-9-4-4-3-NA-8-8 ND 88
H073180204 PT 42 AMP, CHL, STR, SUL, 
TET, TMP/blaTEM-1,
catA2, strA-strB, sul1, 
sul2, tet(A), dfrA7
700 bp/dfrA7 spvA, spvB, spvC, 
spvR, rsk, rck, mig-5, 
srgB, srgC, pefA, 
pefB, pefC, pefD
2-13-9-4-4-3-NA-8-8 ND 92
H091340084 PT 42 AMP, CHL, STR, SUL, 
TET, TMP/blaTEM-1,
catA2, strA-strB, sul1, 
sul2, tet(A), dfrA7
700 bp/dfrA7 spvA, spvB, spvC, 
spvR, rsk, rck, mig-5, 
ǻsrgA, srgB, srgC, 
pefA, pefB, pefC, 
pefD
2-9-9-4-4-3-NA-8-8 ST11 90
H091800482 PT 42 AMP, CHL, STR, SUL, 
TET, TMP/blaTEM-1,
catA2, strA-strB, sul1, 
sul2, tet(A), dfrA7
700 bp/dfrA7 spvA, spvB, spvC, 
spvR, rsk, rck, mig-5, 
srgB, srgC, pefA, 
pefB, pefC, pefD
2-13-9-4-4-3-NA-8-8 ND 92
H095100307 PT 42 AMP, CHL, STR, SUL, 
TET, TMP/blaTEM-1,
catA2, strA-strB, sul1, 
sul2, tet(A), dfrA7
700 bp/dfrA7 spvA, spvB, spvC, 
spvR, rsk, rck, mig-5, 
ǻsrgA, srgB, srgC, 
pefA, pefB, pefC, 
pefD
2-13-9-4-4-3-NA-8-8 ND 95
H100240198 PT 42 AMP, CHL, STR, SUL, 
TET, TMP/blaTEM-1,
catA2, strA-strB, sul1, 
sul2, tet(A), dfrA7
700 bp/dfrA7 spvA, spvB, spvC, 
spvR, rsk, rck, mig-5, 
ǻsrgA, srgB, srgC, 
pefA, pefB, pefC, 
pefD
2-13-9-4-4-3-NA-8-8 ND 95
H101700366 PT 42 AMP, CHL, STR, SUL, 
TET, TMP/blaTEM-1,
catA2, strA-strB, sul1, 
sul2, tet(A), dfrA7
700 bp/dfrA7 spvA, spvB, spvC, 
spvR, rsk, rck, mig-5, 
ǻsrgA, srgB, srgC, 
pefA, pefB, pefC, 
pefD
2-13-9-4-4-3-NA-8-8 ND 95
*pSEV, serovar-specific V plasmid of S.enterica serovar Enteritidis; MLVA, multilocus variable number tandem repeat analysis; MLST, multilocus 
sequence typing; VR, virulence-resistance; PT, phage type; NA, no amplification from this locus; AMP, ampicillin;  CHL, chloramphenicol;  STR 
streptomycin; SUL, sulfonamides; TET, tetracycline; TMP, trimethoprim; ST, sequence type; ND, not done.  
†Size of the variable region amplified with the 5cCS and 3cCS primers (2).
‡All plasmids were positive for IncFIIA, IncFIB and the par locus. Two new primer pairs were devised for detection of srgA: srgAB-Fw1/Rv1 (5c-
CGCCTTCCGTGTATGTCC/GCGAGTCACTCACCGACAG-3c) and srgAB-Fw2/Rv2 (5c-GTTGCACAGGAGTGGGAGTC/GTCCGGGTTCCATGTCAG-3c).
The forward primers anneal at different positions within srgA; the reverse primers anneal at different positions within srgB.Protection Agency Salmonella Reference Unit for phage typing; 
and I. Montero for help with MLST. We are grateful to R. Helmuth 
for his advice and critical reading of the manuscript. 
This study was supported by the Health Protection Agency, 
the Federal Institute for Risk Assessment (BfR-46-001; 45-005), 
and the “Fondo de Investigación Sanitaria” of the “Instituto de 
Salud Carlos III” of Spain (project FIS PI11/00808, cofunded 
by the European Regional Development Fund of the European 
Union: a Way of Making Europe). I.R. received a postdoctoral 
grant from Fundación Ramón Areces, Madrid, Spain.
For strain requests, contact the Health Protection Agency 
Colindale, email: katie.hopkins@hpa.org.uk.
Dr Rodríguez is a postdoctoral fellow at the Federal 
Institute for Risk Assessment in Berlin, Germany, in the Unit 
of Antimicrobial Resistance and Resistance Determinants of 
the Department of Biological Safety. Her research focuses on 
the genotypic characterization of antimicrobial drug resistance 
and the molecular epidemiology of gram-negative drug-resistant 
bacteria.
References 
  1.   Graham  SM.  Nontyphoidal  salmonellosis  in  Africa.  Curr 
Opin Infect Dis. 2010;23:409–14. http://dx.doi.org/10.1097/
QCO.0b013e32833dd25d
  2.   Rodríguez I, Rodicio MR, Herrera-León S, Echeita A, Mendoza 
MC. Class 1 integrons in multidrug-resistant non-typhoidal Sal-
monella enterica isolated in Spain between 2002 and 2004. Int J 
Antimicrob Agents. 2008;32:158–64. http://dx.doi.org/10.1016/j.
ijantimicag.2008.03.005
    3.    Chu C, Chiu CH. Evolution of the virulence plasmids of non-
typhoid  Salmonella and its association with antimicrobial resis-
tance. Microbes Infect. 2006;8:1931–6. http://dx.doi.org/10.1016/j.
micinf.2005.12.026
  4.   Rodicio MR, Herrero A, Rodríguez I, García P, Montero I, Beu-
tlich J, et al. Acquisition of antimicrobial resistance determinants 
by virulence plasmids speciﬁ  c for nontyphoid serovars of Salmo-
nella enterica. Rev Med Microbiol. 2011;22:55–65. http://dx.doi.
org/10.1097/MRM.0b013e328346d87d
  5.   Rodríguez I, Guerra B, Mendoza MC, Rodicio MR. pUO-SeVR1 
is an emergent virulence-resistance complex plasmid of Salmonella 
enterica serovar Enteritidis. J Antimicrob Chemother. 2011;66:218–
20. http://dx.doi.org/10.1093/jac/dkq386
  6.   Fierer  J.  Extraintestinal  Salmonella infections: the signiﬁ  cance 
of the spv genes. Clin Infect Dis. 2001;32:519–20. http://dx.doi.
org/10.1086/318505
  7.   Kado CI, Liu S-T. Rapid procedure for detection and isolation of 
large and small plasmids. J Bacteriol. 1981;145:1365–73.
  8.   Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. 
Identiﬁ   cation of plasmids by PCR-based replicon typing. J Mi-
crobiol Methods. 2005;63:219–28. http://dx.doi.org/10.1016/j.
mimet.2005.03.018
  9.   Ward LR, de Sa JD, Rowe B. A phage-typing scheme for Salmo-
nella enteritidis. Epidemiol Infect. 1987;99:291–4. http://dx.doi.
org/10.1017/S0950268800067765
10.    Malorny B, Junker E, Helmuth R. Multi-locus variable-number 
tandem repeat analysis for outbreak studies of Salmonella enteri-
ca serotype Enteritidis. BMC Microbiol. 2008;8:84. http://dx.doi.
org/10.1186/1471-2180-8-84
11.   Vaagland H, Blomberg B, Krüger C, Naman N, Jureen R, Langeland 
N. Nosocomial outbreak of neonatal Salmonella enterica serotype 
Enteritidis meningitis in a rural hospital in northern Tanzania. BMC 
Infect Dis. 2004;4:35. http://dx.doi.org/10.1186/1471-2334-4-35
12.   Kariuki S, Revathi G, Kariuki N, Kiiru J, Mwituria J, Hart CA. 
Characterisation of community acquired non-typhoidal Salmonella 
from bacteremia and diarrhoeal infections in children admitted to 
hospital in Nairobi, Kenya. BMC Microbiol. 2006;6:101. http://
dx.doi.org/10.1186/1471-2180-6-101
13.   Akinyemi KO, Philipp W, Beyer W, Böhm R. Application of phage 
typing and pulsed-ﬁ  eld gel electrophoresis to analyse Salmonella 
enterica isolates from a suspected outbreak in Lagos, Nigeria. J In-
fect Dev Ctries. 2010;4:828–33. http://dx.doi.org/10.3855/jidc.744
14.   Krauland MG, Marsh JW, Paterson DL, Harrison LH. Integron-me-
diated multidrug resistance in a global collection of nontyphoidal 
Salmonella enterica isolates. Emerg Infect Dis. 2009;15:388–96. 
http://dx.doi.org/10.3201/eid1503.081131
15.    Kingsley RA, Msefula CL, Thomson NR, Kariuki S, Holt KE, 
Gordon MA, et al. Epidemic multiple drug resistant Salmonella 
Typhimurium causing invasive disease in sub-Saharan Africa have 
a distinct genotype. Genome Res. 2009;19:2279–87. http://dx.doi.
org/10.1101/gr.091017.109
Address for correspondence: Irene Rodríguez, Federal Institute for Risk 
Assessment, Diedersdorfer Weg 1, D-12277 Berlin, Germany; email: 
rodriguezﬁ  rene@uniovi.es
DISPATCHES
1176  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 18, No. 7, July 2012
Scan this QR Code with your 
smartphone and enjoy listening 
to our podcasts about the latest 
emerging infectious diseases.
http://wwwnc.cdc.gov/eid/podcasts.htm